pI: 7.4108 |
Length (AA): 561 |
MW (Da): 62009 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 554 | 4e3x (A) | 21 | 562 | 44.00 | 0 | 1 | 1.48822 | -0.76 |
11 | 557 | 4jdc (A) | 3 | 543 | 44.00 | 0 | 1 | 1.54784 | -0.72 |
42 | 543 | 4oe6 (A) | 53 | 562 | 52.00 | 0 | 1 | 1.48063 | -0.55 |
52 | 542 | 1ag8 (A) | 22 | 494 | 23.00 | 0.00012 | 1 | 1.08592 | -0.26 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128522)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_04205 | Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial precursor |
Candida albicans | CaO19.3974 | delta-1-pyrroline-5-carboxylate dehydrogenase |
Candida albicans | CaO19.11457 | delta-1-pyrroline-5-carboxylate dehydrogenase |
Caenorhabditis elegans | CELE_F56D12.1 | Protein ALH-6, isoform D |
Dictyostelium discoideum | DDB_G0283293 | hypothetical protein |
Drosophila melanogaster | Dmel_CG7145 | delta-1-Pyrroline-5-carboxylate dehydrogenase 1 |
Escherichia coli | b1014 | fused DNA-binding transcriptional regulator/proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase |
Homo sapiens | ENSG00000159423 | aldehyde dehydrogenase 4 family, member A1 |
Leishmania braziliensis | LbrM.03.0210 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Leishmania donovani | LdBPK_030190.1 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Leishmania infantum | LinJ.03.0190 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Leishmania major | LmjF.03.0200 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Leishmania mexicana | LmxM.03.0200 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Loa Loa (eye worm) | LOAG_07106 | delta-1-pyrroline-5-carboxylate dehydrogenase |
Mus musculus | ENSMUSG00000028737 | aldehyde dehydrogenase 4 family, member A1 |
Mycobacterium tuberculosis | Rv1187 | Probable pyrroline-5-carboxylate dehydrogenase RocA |
Mycobacterium ulcerans | MUL_0932 | pyrroline-5-carboxylate dehydrogenase, RocA |
Saccharomyces cerevisiae | YHR037W | 1-pyrroline-5-carboxylate dehydrogenase |
Schistosoma japonicum | Sjp_0107580 | expressed protein |
Schistosoma japonicum | Sjp_0203100 | ko:K00294 1-pyrroline-5-carboxylate dehydrogenase [EC1.5.1.12], putative |
Schistosoma mansoni | Smp_065060 | aldehyde dehydrogenase |
Schmidtea mediterranea | mk4.000753.03 | Putative aldehyde dehydrogenase |
Trypanosoma brucei gambiense | Tbg972.10.4060 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Trypanosoma brucei | Tb927.10.3210 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Trypanosoma congolense | TcIL3000_10_2660 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.510943.50 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.509351.10 | delta-1-pyrroline-5-carboxylate dehydrogenase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0539 | bifunctional proline dehydrogenase/pyrroline-5-carboxylate dehydrogenase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1208 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.10.3210 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.3210 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.3210 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.3210 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1014 | Escherichia coli | non-essential | goodall |
CELE_F56D12.1 | Caenorhabditis elegans | slow growth | wormbase |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Aldehyde dehydrogenase | 519 aa | 28.4% | 454 aa | Compounds | References |
Rattus norvegicus | Aldehyde dehydrogenase 1A1 | 501 aa | 26.9% | 453 aa | Compounds | References |
Rattus norvegicus | Aldehyde dehydrogenase, cytosolic 1 | 501 aa | 26.7% | 454 aa | Compounds | References |